It’s a moment many parents have anxiously awaited for months: Children younger than five years are now eligible for vaccination against the coronavirus, among the last Americans to qualify. Wit...

As people across the world grapple with the prospect of living with the coronavirus for the foreseeable future, one question looms large: how soon before they need yet another shot? Not for many mont...

Last week's European Union-African Union summit brought conflicting news about mRNA vaccine production in Africa. Two days after BioNTech executives announced plans to export a version of its Mar...

Research by Indian scientists has suggested that people infected with omicron after full immunisation with the AstraZeneca or Pfizer-BioNTech Covid-19 vaccines have significant immune responses that p...

Booster shots of the Pfizer-BioNTech and Moderna vaccines aren’t just preventing infections with the contagious Omicron variant —  they’re also keeping infected Americans from e...

Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their Covid-19 vaccine against the virus, including the Delta var...

India's government will not buy COVID-19 shots from Pfizer/BioNTech and Moderna, three government sources told Reuters, mainly because domestic output of more affordable and easier-to-store vaccin...

Global pharma major Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralizing antibody response in children aged five to 11 years,...

The Delta variant of the SARS-CoV-2 virus, that causes Covid-19, is unable to evade the antibodies generated by vaccination, according to a lab study. The findings, published in the journal Immunity,...

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University ...